Defunct Company
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
151
NCT03691207
A Study Of AL101In Patients With Adenoid Cystic Carcinoma (ACC) Bearing Activating Notch Mutations
Phase: Phase 2
Role: Lead Sponsor
Start: Dec 14, 2018
Completion: Dec 2, 2022
NCT04461600
A Study of AL101 Monotherapy in Patients With Notch Activated Triple Negative Breast Cancer
Start: Aug 14, 2020
Completion: Oct 11, 2022
NCT04706845
Understanding the Burden of ACC Through the Eyes of Patients
Phase: N/A
Start: Jan 11, 2021
Completion: Aug 16, 2023